Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 1.76 is 77% below its 5-year average of 7.76, near the low end of its 5-year range (1.66–16.13).
As of the fiscal period ended Tuesday, June 30, 2026. 42.78% below its 12-month average of 3.07.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.76.
CURRENT RATIO
1.76
CURRENT RATIO AVG TTM
3.07
CURRENT RATIO AVG 3Y
6.24
CURRENT RATIO AVG 5Y
7.76
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-42.78%
CURRENT VS 3Y AVG
-71.87%
CURRENT VS 5Y AVG
-77.38%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.75
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
-53.20%
vs the sector median at left
Market Cap
$76.24M
Current Ratio
0.14
TTM Avg
0.07
3Y Avg
0.07
5Y Avg
0.07
Market Cap
$78.07M
Current Ratio
1.00
TTM Avg
2.08
3Y Avg
2.75
5Y Avg
4.86
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| SkinHealth Systems Inc. (SKIN) | $76.54M | 1.76 | 3.07 | 6.24 | 7.76 |
| Outset Medical, Inc. (OM)vs › | $76.56M | 5.19 | 6.18 | 6.20 | 7.03 |
| Neonc Technologies Holdings, Inc. (NTHI)vs › | $76.24M | 0.14 | 0.07 | 0.07 | 0.07 |
| Sera Prognostics, Inc. (SERA)vs › | $77.72M | 1.98 | 1.80 | 2.98 | 4.38 |
| Pulmonx Corporation (LUNG)vs › | $75.06M | 4.32 | 5.33 | 6.57 | 9.68 |
| Inovio Pharmaceuticals, Inc. (INO)vs › | $78.07M | 1.00 | 2.08 | 2.75 | 4.86 |
| vTv Therapeutics Inc. (VTVT)vs › | $78.44M | 12.48 | 10.44 | 6.35 | 4.73 |
| Citius Oncology, Inc. (CTOR)vs › | $78.55M | 0.73 | 0.45 | 0.43 | 0.43 |
| Hyperfine, Inc. (HYPR)vs › | $73.90M | 6.15 | 5.25 | 8.81 | 10.73 |
| Verrica Pharmaceuticals Inc. (VRCA)vs › | $73.57M | 1.45 | 2.17 | 5.05 | 3.92 |
Current Ratio
1.76
Quick Ratio
1.48
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 1.76 |
| 2026-03-31 | 1.79 |
| 2025-12-31 | 1.66 |
| 2025-09-30 | 4.98 |
| 2025-06-30 | 5.15 |
| 2025-03-31 | 7.47 |
| 2024-12-31 | 7.00 |
| 2024-09-30 | 6.56 |
| 2024-06-30 | 6.49 |
| 2024-03-31 | 6.57 |
| 2023-12-31 | 6.07 |
| 2023-09-30 | 5.86 |
| 2023-06-30 | 9.28 |
| 2023-03-31 | 10.35 |
| 2022-12-31 | 10.92 |
| 2022-09-30 | 11.68 |
| 2022-06-30 | 11.44 |
| 2022-03-31 | 14.25 |
| 2021-12-31 | 13.09 |
| 2021-09-30 | 16.13 |
| 2021-06-30 | 4.42 |
| 2021-03-31 | 1.60 |
| 2020-12-31 | 1.91 |
| 2020-09-30 | 2.56 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
| 2019-12-31 | 1.43 |
